UK Edition
AdvertiseSubmit Company
Pharma JournalEvidence-Based Pharmaceutical Intelligence
INSIGHTS & ANALYSIS

Industry Intelligence

Evidence-based coverage of pharmaceutical development, regulatory affairs, and biotech innovation

Research15 May 2025· 10 min read

KAIST's Breakthrough: Reprogramming Colon Cancer Cells to Behave Normally

In the long and often punishing battle against cancer, modern medicine has relied heavily on eradication: cut, burn, poison — remove the disease before it removes the patient. While effective in many

By Dr. Eleanor Vance, Regulatory Affairs Editor

News2 May 2025· 7 min read

Unlocking the Hidden Power of Vitamin D for Whole-Body Health

Often associated solely with strong bones and calcium absorption, Vitamin D is now recognised as a far-reaching contributor to systemic health. What was once viewed narrowly as a micronutrient is incr

By James Whitfield, Manufacturing & Supply Chain Writer

Research1 May 2025· 12 min read

Who Owns Your DNA? Law, Ethics, and the Future of Genetic Information

The genetic revolution has delivered extraordinary advances in how we understand, diagnose, and treat disease. With a simple saliva test, we can trace ancestry, assess inherited risk factors, or contr

By Dr. Eleanor Vance, Regulatory Affairs Editor

Research28 April 2025· 14 min read

Rewriting the Future of Liver Health: New Insights and Innovations in NAFLD/NASH Research

Non-alcoholic fatty liver disease (NAFLD) has evolved into one of the most pressing global health concerns of the 21st century. Closely linked to rising rates of obesity and type 2 diabetes, it affect

By Dr. Eleanor Vance, Regulatory Affairs Editor

Wellness23 April 2025· 5 min read

Unlocking the Benefits of Vitamin D for Detox and Lasting Wellness

Why Vitamin D Deserves the Spotlight Vitamin D has long been celebrated for its role in bone health, but recent research suggests it plays a far broader role in human wellness. From supporting the imm

By Megan Liu, Digital Health Reporter

Research22 April 2025· 11 min read

Unlocking Healing: How MDMA Could Transform PTSD Treatment in the UK

In recent years, post-traumatic stress disorder (PTSD) has increasingly come under the spotlight as one of the most complex and stubborn mental health conditions confronting both clinicians and patien

By Dr. Eleanor Vance, Regulatory Affairs Editor

Pharmaceutical11 April 2025· 7 min read

Comprehensive Analysis of PP353 for Chronic Low Back Pain

Chronic low back pain (cLBP), defined as pain persisting for over three months, is a widespread condition affecting millions globally. It is a leading cause of disability and places a significant stra

By Priya Raghavan, Biotech & Markets Analyst

Cancer21 March 2025· 13 min read

Discover how aspirin could revolutionise cancer prevention today

Cancer remains one of the most serious health challenges in the world, with millions of people affected by various forms of the disease each year. In recent years, however, a simple over-the-counter m

By Tom Okafor, Clinical Trials Correspondent

Research20 March 2025· 5 min read

Breakthroughs in Coeliac Disease Research: Progress Towards a Cure

Coeliac disease is a chronic autoimmune disorder triggered by gluten consumption in genetically predisposed individuals. Affecting millions worldwide, it leads to intestinal damage, nutrient malabsorp

By Dr. Eleanor Vance, Regulatory Affairs Editor

Research17 March 2025· 8 min read

The Next Generation of Autoimmune Therapies is Here

Autoimmune diseases affect millions worldwide, with conditions like rheumatoid arthritis, lupus, and multiple sclerosis disrupting daily life for patients. These disorders occur when the body's immune

By Dr. Eleanor Vance, Regulatory Affairs Editor

Pharmaceutical14 March 2025· 5 min read

The Future of HIV Prevention Looks Bright with an Annual Injection

For decades, scientists have been searching for ways to make HIV prevention easier and more effective. The latest breakthrough – an annual HIV jab – might just be the most promising development yet. U

By Priya Raghavan, Biotech & Markets Analyst

Pharmaceutical10 March 2025· 7 min read

Surprising Evidence Shows Aspirin Might Reduce Cancer Risks

For decades, aspirin has been the unsung hero of medicine cabinets across the world. From soothing headaches to reducing heart attack risks, it has earned its reputation as a household staple. However

By Priya Raghavan, Biotech & Markets Analyst

Stay ahead of the curve

Subscribe to our weekly pharmaceutical intelligence digest

Browse

Popular Categories in Pharma Journal

OncologyBiotechnologyPharmaceutical CompaniesClinical ResearchRegulatory, Quality & ComplianceMedical Devices, Diagnostics & EquipmentImmunology & Inflammation
Neuroscience & CNSInfectious Disease & VaccinesRare DiseasesAnimal & Veterinary HealthIndustry Media & AssociationsCell & Gene TherapyDermatology & Aesthetics
Genomics & Precision MedicineRespiratoryCardiovascular & MetabolicContract ManufacturingConsulting, Advisory & MedCommsHaematologyOphthalmology
Private Medical Clinics (London)Recruitment & TalentDigital Health & AIFertility & IVFLab, Reagents & Research ToolsMedical & Health InsuranceWomen's Health

We use cookies and analytics to understand how the site is used and to keep the service free. Choose Accept All to allow this, or Essential Only to use just the cookies we need to keep the site working. You can change your choice any time in our Cookie Policy